Treatment of Early-Stage Colorectal Cancer

Publication Date: February 25, 2019

Key Points

Key Points

  • Historically, some of the highest incidence rates for colorectal cancers have been in “more developed” regions. However, approximately 45% of these occur in “less developed” regions, representing 9-10% of cancers in those populations.
  • Since different regions of the world, both among and within countries, differ with respect to resource access, ASCO has established a process for stratifying guidelines according to resource availability (basic, limited, enhanced and maximal – See Table 1). This framework emphasizes that variations occur not only between but also within countries—for example, between rural and urban areas.

Treatment

Treatmen...

...ramework of Resource Stratification...


...tic, non-obstructing colon cancer...

...with non-obstructing, resectable, localized...

...ts with non-obstructing, resectable, loc...

...h non-obstructing, resectable, localize...


...Stages IIB-IIC: T4N0 (Non-obstructi...

...atients with non-obstructing, locally advan...

...on-obstructing, locally advanced (ie...

...th non-obstructing, locally advanced (ie., with...

...non-obstructing, locally advanced (ie., with inv...

...n-obstructing, locally advanced (ie., with...

...s with non-obstructing, locally advanced (i...

...ients with non-obstructing, resectable, locally ad...


...cer Stages IIB-IIC: T3N0 Obstructing or T4N0 (Ob...

...structing, locally advanced (ie., with invasio...

...bstructing, locally advanced (ie.,...

...h obstructing, locally advanced (ie., w...

...obstructing, locally advanced (ie....

...s with obstructing, locally advanced (ie., with i...


...gh-Risk Obstructing Colon Cancer and Colon Canc...

...atients with obstructing, locally advanced (...

Patients with high-risk, obstructing stage...

...ients with high risk, obstructing stage III...


...Cancer Stage I– clinical stage T1 N0

...atients with nonmetastatic cT1N0 rectal...

...with nonmetastatic cT1N0 rectal cancerEnhanced and...

Patients with select low risk (cT1N0 withou...


...Cancer Stage I– clinical stage T2...

...s with nonmetastatic cT2N0 rectal cancerBasic a...

...s with nonmetastatic cT2N0 rectal cancerEnhan...

...nonmetastatic cT2N0 rectal cancerM...


...Cancer Stage IIA– clinical stage T3 N0...

...linically resectable cT3N0 rectal cancerBasic an...

...atients with clinically resectable cT3N0 re...

...h clinically resectable cT3N0 rectal canc...

Patients with clinically resectable cT3N0 rec...

...clinically resectable cT3N0 rectal cancer where...

...clinically resectable cT3N0 rectal cancerEnhanc...

...linically resectable pT3N0 rectal...

...with clinically resectable cT3N0 rectal...

...h clinically resectable cT3N0 rectal...


...-Stage Colon Cancer Post-Treatment Sur...

...ted patients with Stage II CRCBasic Medical...

...ed patients with Stage II CRCLimited Me...

...ated patients with Stage II CRC at st...

...atients with Stage II CRC at high riskEnha...

...ents with Stage II CRC at standard and high riskM...


...ectal Cancer Post-Treatment Surveillanc...

...ients with rectal cancerBasic Medical histor...

...tients with rectal cancer at stand...

...ts with rectal cancer at high riskEn...

...nts with rectal cancer who have not received p...

...s with rectal cancer at standard r...

...patients with rectal cancer at standard...

...with rectal cancer at high risk who have not rece...

...eated patients with rectal cancer, where a compl...

...patients with rectal cancer at high...


...Early-Stage Colon Cancer Follow Up (summa...


.... Early-Stage Rectal Cancer Follow Up (...